Evidence map›Paper›PMID 30082285›Full record

ArticleAntimicrobial agents and chemotherapy2018

Clinical and Molecular Correlates of Escherichia coli Bloodstream Infection from Two Geographically Diverse Centers in Rochester, Minnesota, and Singapore.

Shehara M Mendis, Shawn Vasoo, Brian D Johnston, Stephen B Porter, Scott A Cunningham, Sanjay R Menon, Christine B Teng, Partha P De, Robin Patel, James R Johnson and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Escherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. Expansion of a Subset Within the C2 Subclade ofOpen forum infectious diseases · 2020
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shehara M Mendis *Department of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
Shawn Vasoo *National Centre for Infectious Diseases, Singapore shawn_vasoo@ttsh.com.sg ritu.banerjee@vanderbilt.edu.ORCID 0000-0001-7812-9881
Brian D JohnstonMinneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, USA.
Stephen B PorterUniversity of Minnesota, Minneapolis, Minnesota, USA.
Scott A CunninghamDivision of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
Sanjay R MenonDepartment of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
Christine B TengDepartment of Pharmacy, National University of Singapore, Singapore.
Partha P DeDepartment of Laboratory Medicine, Tan Tock Seng Hospital, Singapore.
Robin PatelDivision of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6344-4141
James R JohnsonMinneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, USA.
Ritu BanerjeeDivision of Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA shawn_vasoo@ttsh.com.sg ritu.banerjee@vanderbilt.edu.

Funding

Mayo Clinic Center for Translational Science ActivitiesKL2RR024151 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$15.3M
Gut reservoir of E. coli ST131I01CX000920 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI JOHNSON, JAMES R · 2014 to 2021
–
CSRD VA I01 CX000920NCRR NIH HHS KL2 RR024151
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacteremiabeta-LactamasesDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFluoroquinolonesMicrobial Sensitivity TestsMinnesotaMolecular EpidemiologyOdds RatioRetrospective StudiesSingaporeVirulence FactorsAnti-Bacterial Agentsbeta-LactamasesEscherichia coli ProteinsFluoroquinolonesVirulence FactorsbacteremiaEscherichia coliH30Rxmedical outcomesST131virulence factors

Identifiers

PMID30082285
PMCPMC6153841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.